CRRT Interactive Hyperkalemia Cases AKI & CRRT conference 2018

Similar documents
CRRT Interactive Hyperkalemia Cases AKI & CRRT conference 2018

CRRT Fundamentals Pre- and Post- Test. AKI & CRRT Conference 2018

ST. DOMINIC-JACKSON MEMORIAL HOSPITAL JACKSON, MISSISSIPPI. CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) HEPARIN ANTICOAGULATION Page 1 of 5

CRRT Fundamentals Pre-Test. AKI & CRRT 2017 Practice Based Learning in CRRT

CRRT Fundamentals Pre- and Post- Test Answers. AKI & CRRT 2017 Practice Based Learning in CRRT

MODALITIES of Renal Replacement Therapy in AKI

Can We Achieve Precision Solute Control with CRRT?

CRRT: The Technical Questions Modality & Dose. Ashita J. Tolwani, MD, MSc University of Alabama at Birmingham 2018

Can We Achieve Precision Solute Control with CRRT?

Managing Acid Base and Electrolyte Disturbances with RRT

Session 1: Circuit, Anticoagulation and Monitoring. Ashita Tolwani, MD, MSc Noel Oabel, BSN, RN, CNN 2019

UNDERSTANDING THE CRRT MACHINE

Admission Day 2 Na Potassium Cl Bicarb BUN Cr Hb Hct platelets

Active UMMC Protocols

UAB CRRT Primer Ashita Tolwani, MD, MSc University of Alabama at Birmingham

Who? Dialysis for Acute Renal Failure: Who, What, How, and When? Kathleen D. Liu, MD, PhD, MAS June 2011

CRRT for the Experience User 1. Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference March, 2018

Implementing therapy-delivery, dose adjustments and fluid balance. Eileen Lischer MA, BSN, RN, CNN University of California San Diego March 6, 2018

higher dose with progress in technical equipment. Continuous Dialysis: Dose and Antikoagulation. prescribed and delivered

Recent advances in CRRT

Nurse-Pharmacist Collaboration in the Delivery of Continuous Renal Replacement Therapy

Acute Kidney Injury (AKI) How Wise is Early Dialysis in Critically Ill Patients? Modalities of Dialysis

Potassium A NNA VINNIKOVA, M. D.

Operation-Fluids-Electrolytes-Acid Base COMPLICATIONS OF DIALYSIS 2

Section 3: Prevention and Treatment of AKI

Dialysis Dose Prescription and Delivery. William Clark, M.D. Claudio Ronco, M.D. Rolando Claure-Del Granado, M.D. CRRT Conference February 15, 2012

End-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology

Clinical Application of CRRT for Infants and Children

CSI (Clinical Scenario Investigation): Hyperkalemia

RENAL FAILURE IN ICU. Jo-Ann Vosloo Department Critical Care SBAH

Management of the patient with established AKI. Kelly Wright Lead Nurse for AKI King s College Hospital

CRRT Procedures. and Guidelines. CRRT: Guidelines

Rationale for renal replacement therapy in ICU: indications, approaches and outcomes. Richard Beale

PICANet Custom Audit Definitions Renal Dataset

PD In Acute Kidney Injury. February 7 th -9 th, 2013

CRRT. ICU Fellowship Training Radboudumc

Timing, Dosing and Selecting of modality of RRT for AKI - the ERBP position statement

ASN Board Review: Acute Renal Replacement Therapies

Continuous Renal Replacement Therapy. Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD

ECMO & Renal Failure Epidemeology Renal failure & effect on out come

Citrate Anticoagulation

Continuous Renal Replacement Therapy

- SLED Sustained Low-Efficiency Dialysis

Pediatric Continuous Renal Replacement Therapy

Renal Replacement Therapy in ICU. Dr. Sunil Sharma Senior Resident Dept of Pulmonary Medicine

Practice Based Learning in CRRT: The Science and the Art Pediatric Session. David Askenazi Theresa Mottes Scott Sutherland

PICANet Custom Audit Definitions Renal Dataset

A Mnemonic for the Treatment of Hyperkalemia. Nick Wolters, PGY1 Resident Grandview Medical Center

Olistic Approach to Treatment Adequacy in AKI

Prolonged Dialysis: 24-hr SLED Is It CRRT? Balazs Szamosfalvi, MD

PICANet Renal Dataset supplement Renal Daily Interventions

Acute Kidney Injury Care in the Chronic Unit

Basic Fluid and Electrolytes

404FM.2 CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) USING CITRATE Target Audience: Hospital only ICU. (Based on Gambro and Kalmar Hospital protocols)

Hyperkalemia Protect, Shift, and Eliminate

HNE Area Intensive Care. Continuous Renal Replacement Therapy in Intensive Care(CRRT)

Wales Critical Care & Trauma Network (North) CITRATE GUIDELINES (Approved May 2015)

Fluid & Electrolyte Balances in Term & Preterm Infants. Carolyn Abitbol, M.D. University of Miami/ Holtz Children s Hospital

Metabolismo del citrato nei pazienti critici. Filippo MARIANO Dipartimento di Area Medica, SCDO di Nefrologia e Dialisi Ospedale CTO, Torino

Normal range of serum potassium is meq/l true hyperkalemia manifests clinically as : Clinical presentation : muscle and cardiac dysfunction

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Dialysis in the Acute Setting

Renal Replacement Therapy in Acute Renal Failure

Electrolyte Imbalance and Resuscitation. Dr. Mehmet Okumuş Sütçü Imam University Faculty of Medicine Department of Emergency Medicine

Management of Acute Kidney Injury in the Neonate. Carolyn Abitbol, M.D. University of Miami Miller School of Medicine / Holtz Children s Hospital

Drug Use in Dialysis

Accelerated Venovenous Hemofiltration: Early Technical and Clinical Experience

Pare. Blalock. Shires. shock caused by circulating toxins treatment with phlebotomy. shock caused by hypovolemia treatment with plasma replacement

Kit Assembly. Enhanced Simplicity OPERATIONAL BENEFITS. Automatic venous chamber adjustment. User friendly interface

Dialyzing challenging patients: Patients with hepato-renal conditions

Decision making in acute dialysis

Technical Considerations for Renal Replacement Therapy in Children

Module 8: Practice Problems

ESPEN Congress Vienna Nutritional implications of renal replacement therapy in ICU Nutritional support - how much nitrogen? W.

Continuous renal replacement therapy. David Connor

MEDICAL EQUIPMENT II HEMODIALYSIS

CRRT in Pediatrics: Indications, Techniques & Outcome. Overview

Hyponatremia is a common electrolyte disturbance

ADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center

FLUIDS AND ELECTROLYTES

Technical aspects of RRT in AKI: access, anticoagulation, drug dosage and nutrition. Marlies Ostermann

Renal replacement therapy in Pediatric Acute Kidney Injury

CRRT: QUALITY MANAGEMENT SYSTEMS

RENAL FAILURE IN CHILDREN Dr. Mai Mohamed Elhassan Assistant Professor Jazan University

Medical therapy of AKI complications. Refik Gökmen AKI Academy 18 October 2014

Regional Citrate Anticoagulation for RRTs in Critically Ill Patients with AKI

The kidney. (Pseudo) Practical questions. The kidneys are all about keeping the body s homeostasis. for questions Ella

Hydrofluoric Acid Toxicity Author: Z. Kazzi / E. A. Numur / S. Kini. Target Audience: Emergency Medicine Residents

When and how to start RRT in critically ill patients? Intensive Care Training Program Radboud University Medical Centre Nijmegen

Calcium (Ca 2+ ) mg/dl

03/19/2019. Michael Zappitelli, MD, MSc Hospital for Sick Children, Toronto. Symposium on Pediatric Dialysis, ADC, Dallas, 2019

Saint-Antoine Hospital, Paris. Medical Intensive Unit Care. Hafid Ait-Oufella, MD.PhD. Dyscalcemia. Dyskalemia

Acute Kidney Injury. Elaine Go, RN, MSN, CNN-NP. Clinical Educator, St. Joseph Hospital Renal Center Nurse Practitioner NSMG Orange, Ca

CCRN Review - Renal. CCRN Review - Renal 10/16/2014. CCRN Review Renal. Sodium Critical Value < 120 meq/l > 160 meq/l

Acute Stroke with Alteplase Administration Order Set

PP-US-DSE Relypsa, Inc. All rights reserved. Relypsa and the Relypsa logo are trademarks of Relypsa, Inc.

Physiology of Blood Purification: Dialysis & Apheresis. Outline. Solute Removal Mechanisms in RRT

Nephrology / Urology. Hyperkalemia Causes and Definition Lecturio Online Medical Library. Definition. Epidemiology of Hyperkalemia.

Continuous Renal Replacement Therapy (CRRT)

Acute Kidney Injury- What Is It and How Do I Treat It?

Transcription:

CRRT Interactive Hyperkalemia Cases AKI & CRRT conference 2018

Case 1 Potassium Clearance A 70 kg male is placed on CVVH with a total ultrafiltration rate (effluent rate) of 20 ml/kg/hr. The Blood Flow Rate is 200 ml/min and the Replacement Fluid is administered Post Filter. The patient s potassium is 5.0 meq/l. What will be the percent change in rate of potassium clearance with increasing the CVVH dose to 25 ml/kg/hr? A. 10% B. 15% C. 20% D. 25% E. 30%

Case 1 The K will be removed 25% faster (There is a 25% change from 20 to 25 ml/kg/hr) An increase in dose of 5 ml/kg/hr over 20 ml/kg/hr is a 25% change 5 ml/kg/hr divided by 20 ml/kg/hr is 0.25

Case 2: Hyperkalemia An 82-year-old man with diabetes, coronary artery disease, and CKD is admitted to the intensive care unit with hypotension from a lower GI bleed attributed to ischemic colitis. He is resuscitated with blood and intravenous (IV) fluids, with improvement in his blood pressure to 108/70 mmhg. However, over the ensuing 24 hours he becomes anuric, and his ECG shows peaked T waves with a prolonged QRS of 140 ms. Laboratory studies show the following: Serum Sodium 138 meq/l Potassium 7.5 meq/l Chloride 102 meq/l Total CO2 17 meq/l BUN 84 mg/dl Creatinine 3.2 mg/dl Calcium 9.4 mg/dl Arterial ph 7.25 He is initiated on CVVH with an effluent dose of 2500 ml/h. Blood flow is set to 150 ml/min, and the replacement fluid potassium is 2.0 meq/l. After 12 hours, his serum potassium remains elevated at 7.2 meq/l.

Case 2 Which of the following is the MOST appropriate next step to correct his persistent severe hyperkalemia? A. Change to intermittent hemodialysis B. Administer two ampules (100 meq) of sodium bicarbonate C. Change to CVVHDF D. Increase the blood flow to 200 ml/min E. Increase effluent dose to 3000 ml/h

Case 2 The etiology for his hyperkalemia is multifactorial: he is receiving potassium with the blood transfusions, there is potassium shift out of cells from both his acidemia and ischemic bowel, and he is not able to excrete this potassium load because he is anuric Increasing the effluent rate of CVVH would be of limited benefit. Assuming a constant plasma K of 7.2 meq/l and an effluent flow rate of 2500 ml/h, 18 meq K will be removed per hour 7.2 meq/l X 2.5 L/h = 18 meq/h However, the replacement fluid contains 2 meq/l potassium, so he will receive 5 meq K per hour, for a net K removal of 13 meq/h. Increasing the effluent dose to 3000 ml/h would only improve this to 15.6 meq/h of K removed (7.2 X 3 L/h = 21.6 meq/h) 2 meq/h X 3 L/h) = 15.6 meq/h. Another option is to use 0 K solution with CVVHD and effluent rate 8 L/hr. K removed would be 7.2 meq/l x 8 L/hr = 58 meq K removed per hour.

Case 3 Hyperkalemia n A 60 year old patient with ESRD due to DM, also with ileostomy, afib on warfarin, is admitted to the ICU for severe hyperkalemia complicated by bradycardia and hypotension. He missed HD x 2 d/t AVG malfunction. Initial labs: K 7.5, Cr 14, Na 140, Cl 120, CO2 9, CK 48, LA 5, vbg 7.13, 34/39/11, Hb 11 INR 6. He is treated with 1 amp calcium gluconate x 2, regular insulin 10 U IV + D50, albuterol 20 mg inhaled, bicarbonate and a temporary pacer, which is not capturing. He remains hypotensive on epinephrine. DW 80 kg. He now has a 24 cm femoral dialysis catheter. The on-call dialysis nurse is a 1.5 hours away. n You have decided to start with CRRT while waiting for the intermittent nurse. n Your pharmacy stocks the following fluids for RF or dialysate and the night pharmacist is willing to compound something for you. n -Ca 0, K 2, HCO3-22 -Ca 3.5, K 4, HCO3-32 -Ca 3.5, K 2, HCO3-32

Case 3 Hyperkalemia n Which of the following is the best prescription? A. Regional citrate anticoagulation + prefilter CVVH 1600 ml/hour (dose 20 ml/kg/hr) using Ca 0, K 2, HCO3-22 B. Regional citrate anticoagulation + CVVHD 1600 ml/hour (dose 20 ml/kg/hr) using Ca 0, K 2, HCO3-22 C. No citrate + CVVHDF with 2000 ml/hour prefilter and 200 ml/hour post filter (dose 50 ml/kg/hr) using Ca 3.5, K 2, HCO3-32 D. Give 60 grams of kayexlate po and wait for the hemo nurse. E. No citrate + CVVHDF with 2000 ml/hour prefilter and 200 ml/hour post filter (dose 50 ml/kg/hr) using Ca 3.5, K 0, HCO3-32 that the pharmacist compounds for you

Case 3 Hyperkalemia n A. Incorrect. Would use higher delivered dose d/t life threatening hyperkalemia. He also is already anticoagulated with INR of 6 and hx of warfarin use. Either high dose CVVH or CVVHD is acceptable n B. Incorrect. Would use higher delivered dose d/t life threatening hyperkalemia. He also is already anticoagulated with INR of 6 and hx of warfarin use. Either high dose CVVH or CVVHD is acceptable n n n C. Correct. Given hyperkalemia and acidosis, would use higher than standard CRRT dose to more quickly correct the electrolyte abnormality. He is already anticoagulated with INR of 6 and hx of warfarin use so no compelling need for citrate D. Incorrect. Kayexlate would be minimally effective in this situation as he has an ileostomy. Also, it would take hours to be effective. He has life threatening hyperkalemia despite aggressive medical management. Would not wait an additional 1.5 hours for the nurse to arrive + at least 0.5 hours for the nurse to get the machine to the ICU and prime before starting treatment. E. Incorrect. In general, it is preferred to use commercially available fluids. These are standard preparations with a quality control process as part of the manufacturing of the fluid. It will take time to determine how to write & enter compounding orders into EMR and for the pharmacist to compound this for you. There may not be a quality control process after compounding. Prolonged use of zero K bath is dangerous esp at a high CRRT dose.